Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota

BackgroundMinimal hepatic encephalopathy (MHE) is an early stage in the pathogenesis of hepatic encephalopathy. Intestinal microbiota is involved in the pathogenesis of hepatic encephalopathy and has become an important therapeutic target. Since there is no unified treatment principle for MHE, this...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Ming-Wei Wang, Wei-Juan Ma, Yan Wang, Xiao-Han Ma, Yu-Feng Xue, Jing Guan, Xi Chen
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2023-03-01
Sarja:	Frontiers in Microbiology
Aiheet:	probiotics rifaximin lactulose minimal hepatic encephalopathy gut microbiota
Linkit:	https://www.frontiersin.org/articles/10.3389/fmicb.2023.1091167/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!